PICC Excellence Launches Ultrasound PIV Mastery Program

Insertion of a peripheral intravenous catheter is the most commonly performed invasive medical procedure among hospitalized patients. When coupled with ultrasound technologies for vascular visualization, well trained clinicians achieve greater first-time procedural success for peripheral IV insertions.

Nancy Moureau, RN, PhD, CRNI, CPUI, VA-BC

According to vascular access expert Nancy Moureau, RN, PhD, CRNI, CPUI, VA-BC, inconsistent and fragmented training can make it difficult for clinicians to establish competency and master the skills needed to perform successful ultrasound-guided peripheral IV insertions.

To address the lack of standardized UGPIV training, Moureau and her team at PICC Excellence developed a comprehensive training program, which recently became the first educational program to be recognized with a Seal of Approval from the Infusion Nurses Society. The INS Seal of Approval is designed to reflect the credibility of education, competency-based training and content that adheres to INS standards for infusion-related practices (see sidebar below).


The Ultrasound Mastery Training Toolbox

The ultimate training package for procedures and best practices, the UGPIV Mastery Training Toolbox provides learners, trainers, and healthcare organizations with a comprehensive approach to mastering UGPIV insertions which ensures proficiency at every step.

The UGPIV Mastery Training program’s systematic process of learning follows established evidence from mastery learning processes which incorporate levels of achievement and accountability.

“Applied to ultrasound-guided peripheral catheter insertions, these instructional methods promote greater patient safety, preserve vessel health, reduce failed insertion attempts, and drive higher-level success with this increasingly common procedure,” says Moureau.

Jon Bell, RN, MSN, VA-BC, CEN

The first UGPIV Mastery Certificate was awarded in January to emergency vascular access expert Jon Bell, RN, MSN, VA-BC, CEN. Bell also completed the instructor mastery training workshop and is now one of PICC Excellence’s UGPIV Mastery instructors.

“One of the biggest challenges with UGPIV insertions is their significant learning curve. Placing IVs under ultrasound guidance isn’t a one-and-done skill; it’s something that takes practice,” says Bell. “Teaching the procedure in a structured, methodical way sets the expectation that mastering this skill requires time and effort and provides a clear pathway which people can commit to from the beginning.”

Program Content

The UGPIV Mastery Training program, as a blended educational approach, combines online courses, simulated practice, and supervised insertions, leading to a final examination to award the UGPIV Mastery Certificate. A resource manual includes detailed instructions for each step of the training and skills module. The tools for collecting insertion data demonstrate training completion and minimal competency.

Mastery Training. Online modules establish a strong foundation for understanding the 3 stations of the needle, and needle signs of ultrasound-guided PIV insertions. Topics include the basics of ultrasound, infection prevention, key concepts of aseptic non-touch technique (ANTT), basic anatomy, vein and catheter selection, probe protection and needling skills, and other necessary elements of ultrasound training.

Guided Practice. Modules for teaching hands-on skills guide clinicians toward achieving the minimum performance score, which must be satisfied before moving on to supervised patient insertions.

Supervised Insertions. Real-world patient insertions are supervised by a preceptor and scored according to the difficulty of the insertion and the level of success in achieving and maintaining PIV access.

Independent Insertions. Clinicians demonstrate competency by collecting data about their first 10 insertions, including dwell time, vein diameter, catheter size, and other factors.

Upon completion of the training elements, candidates receive access to the program’s final examination. Passing the exam entitles candidates to UGPIV Mastery Certification and inclusion in the PICC Excellence online mastery certificate registry.

“This course is a game changer because it standardizes the learning process,” says Bell. “It ensures people are receiving consistent messaging for the entire duration of their training—even if it’s with different instructors. They’re not dependent on learning my way, and then having to learn another way with a different instructor.”

The course can be purchased by individuals or via a multi-user licensing package for hospitals or other organizations.

Widespread Benefits

The use of UGPIV techniques has expanded to many healthcare specialties, helping clinicians achieve success even for patients who present with difficult vascular access conditions. The UGPIV Mastery program benefits clinicians in any specialty where venous access may be required, including emergency departments, intensive care units, surgery departments, outpatient infusion or oncology centers, and home-care settings.

The program is not limited to beginners, nor does it require a previous level of knowledge or expertise. Those who are new to UGPIV procedures benefit from the program’s standardized, step-by-step instruction process. For experienced inserters, the package includes train-the-trainer preceptor skills to help them learn how to train other clinicians. These more experienced clinicians benefit from the program’s streamlined and systematic instruction, which helps them implement UGPIV techniques successfully across their organization. Testimonials of advanced inserters state they have become even more proficient by using the needling signs and skills included in the UGPIV Mastery Package.

“Even someone who’s already good at UGPIV insertion can get better,” says Moureau. “Regardless of where a candidate is starting from, the course provides a standardized roadmap to give them the tools and skills needed to be successful every time.”

Mastering Ultrasound Practices

The PICC Excellence UGPIV Mastery program makes use of the concepts and requirements found in the latest edition of the INS Infusion Therapy Standards of Practice. The INS standards recommend that organizations:

  • Establish comprehensive training programs for ultrasound-guided procedures, supporting clinicians throughout the novice-to-expert continuum.
  • Assess and document clinician competency in the use of vascular visualization technologies for the insertion of vascular access devices. Competencies should include assessment of vessel size, depth, and location; potential complications; and adherence to aseptic non-touch technique (ANTT).

The UGPIV Mastery program emphasizes instruction in clinical capabilities that are essential for safely achieving venous access. Two examples:

Needling Skills. Both the online and simulated portions of the UGPIV Mastery program emphasize the need for clinicians to achieve needling skills prior to undertaking real-world patient insertions. Course instruction includes understanding the significance of the three stages of needle insertion and identifying key visual signs indicating needle position on the ultrasound screen.

Aseptic Procedure. As a necessary component of the safety process for ultrasound-guided PIV insertions, the program demonstrates how sterile probe covers or sterile barrier and securement dressings can protect patients from infection with pathogens transmitted via touch or contaminated gel. When combined with basic ANTT principles, probe covers or barrier dressings provide sufficient protection without the need for a fully sterile procedure, which is costly and not justified based on current literature.

“Receiving the INS Seal of Approval award acknowledges the PICC Excellence UGPIV Mastery Training program adheres to the INS Standards of Practice,” says Moureau. “This ultrasound Mastery Toolbox is the first systematic competency-based training program that takes a learner from zero to trainer. The levels of achievement provide measurement ratings and complete documentation which can be used by the institution demonstrating competent performance of the procedure.”


The Evolution of Thought Leadership in the MedTech Industry: Insights from Jeff Jones

In the rapidly advancing world of medical technology, establishing credibility and trust is paramount. And one of the best ways to establish that credibility is to seek—and follow—the advice of prominent experts in a particular medtech field. Combined with a strategic public relations strategy, such key opinion leaders (KOLs) can then help raise awareness and provide an invaluable validation of a technology’s importance and value. Together, thought leaders and PR experts enable businesses to gain media exposure, present results at scientific meetings, and secure speaking engagements at industry conferences, thus raising the companies’ visibility and credibility.

Jeffrey Jones, Managing Partner at The Deerborne Group, a global diagnostics and life sciences consulting firm, has learned the importance of key opinion leaders over the course of a long and successful career at both Fortune 500 companies like Abbott, Bayer, and Quest Diagnostics and venture-backed startups like Agendia, which offers genomic testing for breast cancers. Here are his insights:

Continue reading “The Evolution of Thought Leadership in the MedTech Industry: Insights from Jeff Jones”

In Controversy over Transducer Disinfection, Intersocietal PoSITION Statement Earns Broad Support

Over the past decade, there has been a dramatic increase in the adoption of point-of-care (POC) ultrasound to improve patient care across a wide variety of medical specialties, including cardiology, emergency medicine, obstetrics and gynecology, orthopedics, vascular access, and more. But the rapid dissemination of POC ultrasound among new medical specialties, combined with conflicting guidance from clinical organizations, has led to widespread confusion about the infection control practices appropriate for POC ultrasound equipment.

In this blog post, we examine the rise of POC ultrasound, the controversy and confusion surrounding transducer disinfection practices, and the details behind a 2021 Intersocietal Position Statement that provides some much-needed clarity on the topic.

Continue reading “In Controversy over Transducer Disinfection, Intersocietal PoSITION Statement Earns Broad Support”

Knowledge is Power – Why you should #KnowYourBiomarker

Republished with permission from the blog of AJ Patel. This is the second post in a series on advances in genomic testing and the future of cancer treatment — see the first post here.

When I was diagnosed 8 years ago with non-small cell lung cancer (NSCLC), I was told I had 6 months to live. It was the worst time of my life, and I wallowed in misery for nearly a week before I decided I needed to take action. I turned to the internet, which at first did nothing to alleviate my misery. But then I stumbled upon the patient advocacy organization LUNGevity and made a phone call that changed the trajectory of my entire diagnosis.

​That one call—and the connections and information that came out of it—are the reason I’m alive today.

Continue reading “Knowledge is Power – Why you should #KnowYourBiomarker”

Breaking Down Barriers – Improving Access to Comprehensive Biomarker Testing for Cancer Patients

This is the first in a series on advances in genomic testing and the future of cancer treatment.

The last two decades have brought remarkable advances in cancer treatment with the use of precision medicine. Twenty years ago, the major weapon doctors had against most advanced cancers was a harsh regimen of chemotherapy — a one-size-fits-all treatment that leaves patients debilitated while offering limited survival.

The shift to more targeted treatments began after researchers discovered that many cancers are driven by mutations in specific genes. This was most robustly exemplified in non-small cell lung cancer (NSCLC). Pharmaceutical companies have now developed more than two dozen drugs for patients with NSCLC that directly target specific genes and mutations, leading to better overall outcomes.

The impact of these advances “has been enormous,” says Dr. Wendy Levin, Chief Medical Officer at Biofidelity, a cancer diagnostic company. “If we can get a patient on a targeted agent that’s more effective and better tolerated, we know that they will have a major survival advantage.”

Continue reading “Breaking Down Barriers – Improving Access to Comprehensive Biomarker Testing for Cancer Patients”

Is it Time to Move Beyond CLABSI?

When it comes to infection control in vascular access, central line-associated bloodstream infections (CLABSIs) certainly get the most attention. Yet the medical community is increasingly recognizing how infections associated with other types of vascular access devices are putting patients at risk.

Take peripheral IV (PIV) catheters, the most commonly used type of vascular access device. Nearly 90 percent of hospitalized patients require a PIV at some point during their stay, and PIV usage far outnumbers that of central vascular access devices (CVAD). PIVs, therefore, account for an infection rate that approaches the CVAD infection rate in absolute terms.

Yet there is currently no mandatory reporting system for bloodstream infections associated with PIVs in the U.S., making it one of the most underreported types of infections in vascular access. Epidemiologist Robert Garcia, an infection preventionist with 40 years of hospital experience, shares these concerns — and he has a plan to address this significant patient safety issue.

Continue reading “Is it Time to Move Beyond CLABSI?”

2021 INS Standards Highlight Anti-Reflux Technology for Needleless Connectors

Guest post by Nancy Moureau, RN, PhD, CEO of PICC Excellence

In vascular access, needleless connectors (NC) are now recommended worldwide to maintain closed IV systems and promote safety by preventing needlestick injuries. Over the past 25 years, many different NCs have come onto the market, with wide variations in design and function among the various types. As a result, there is a lot of confusion among clinicians regarding the proper use and management of these small yet complex devices, which can have serious patient safety implications.

Fortunately, the Infusion Nurses Society provides some clarity on this issue by significantly expanding its guidance on NCs in the 2021 Infusion Therapy Standards of Practice. This includes clearer definitions of the various types of NC technology and emphasizes the importance of understanding how to use each type properly to minimize blood reflux.

Many clinicians are not aware of the impact blood reflux can have, or view it as a minor issue that can be easily addressed with proper flushing. However, evidence is mounting that reflux is largely avoidable and leads to many complications that seriously impact patient safety.

Continue reading “2021 INS Standards Highlight Anti-Reflux Technology for Needleless Connectors”

UGPIV Practices: Are they jeopardizing patient safety?

A new continuing education program details how a lack of standardized policies related to ultrasound-guided peripheral IV (UGPIV) catheter insertions can negatively impact patient safety. The webinar also suggests UGPIV performance improvement initiatives that “can help to create a culture of safety across the healthcare continuum,” according to presenter Nancy Moureau, RN, PhD, an internationally recognized expert and consultant in vascular access and CEO of PICC Excellence.

The on-demand webcast, Patient Safety and Ultrasound-Guided Peripheral IV Placement: The Need for Standardized Practices, offers 1 contact hour of continuing education for nurses. It is sponsored by Parker Laboratories.

“While the use of ultrasound guidance to improve success during PIV catheter placements is becoming more common, suboptimal aseptic technique and variations in supply usage poses a very serious risk to patients,” said Dr. Moureau. “To increase safety during UGPIV insertions, healthcare organizations should adopt a multidisciplinary approach to standardize policies and procedures based on current evidence and recommendations, while at the same identifying opportunities for pragmatic, incremental improvements.”

Continue reading “UGPIV Practices: Are they jeopardizing patient safety?”

The Future of Breast Cancer Treatment: Destroying Tumors with a Laser

Breast cancer patients have long been in need of reliable therapeutic options that reduce pain and the risk of disfigurement. At the forthcoming MedTech conference of the Advanced Medical Technology Association (AdvaMed, Washington, DC), laser therapy specialist Novian Health Inc (Chicago) will showcase a novel technology for the ablation of early-stage breast tumors. The company’s CE-marked system is seeking to displace existing surgical procedures as the treatment of choice for early-stage breast tumors.

Every year, more than 275,000 women in the United States and 2 million around the world receive the dreaded diagnosis of breast cancer. The news can be overwhelming, triggering sudden and intense emotions. One participant in a study of patient responses to a breast cancer diagnosis said she felt “paralyzed and frozen with fear.”

Continue reading “The Future of Breast Cancer Treatment: Destroying Tumors with a Laser”

D&D remembers Regis Philbin

While this post is a departure from our usual medicine-focused content, we at D&D wanted to acknowledge the recent passing of Regis Philbin. A few members of our staff were fortunate enough to meet Regis during his 88 years on earth — their reminiscences are below.

From Greg Dennis, retired co-founder of Dowling & Dennis:

Regis Philbin had a son who was confined to a wheelchair and relied upon a small piece of technology made by a large medical company. As it happened, Dowling & Dennis did some PR consulting work for that company.

Continue reading “D&D remembers Regis Philbin”